Opportunity Information: Apply for 72051718RFA00003
USAID, through its mission in the Dominican Republic and under the President's Emergency Plan for AIDS Relief (PEPFAR), issued a continuation funding opportunity to support the HIV Services and Systems Strengthening (HS3) program. The award mechanism is a cooperative agreement, meaning the implementer would carry out the work with substantial involvement from USAID. The program is positioned as a multi-year effort (2018 to 2023) focused on helping the Government of the Dominican Republic (GoDR) move closer to HIV epidemic control while strengthening the underlying health system so gains can be sustained and eventually transitioned away from donor support.
The central goal of HS3 is to accelerate progress toward the global 90-90-90 HIV targets: 90 percent of people living with HIV knowing their status, 90 percent of those diagnosed receiving sustained antiretroviral therapy, and 90 percent of those on treatment achieving viral suppression. HS3 is designed to do this by improving clinical care and service delivery using a health systems strengthening (HSS) approach, not just by expanding individual services. In practical terms, the activity emphasizes building a more responsive and scalable HIV service platform that can adapt to changing needs, address bottlenecks in the system, and remove barriers that keep people from testing, linking to care, staying on treatment, and reaching viral suppression.
A major program focus is ensuring that HIV services effectively reach and serve key and priority populations that are disproportionately affected or face greater access barriers. The opportunity defines key populations as men who have sex with men (MSM), transgender individuals (TG), and female sex workers (FSW). It defines priority populations as migrants of Haitian descent. HS3 aims to deliver targeted, high-impact service packages for these groups while also reinforcing the broader service environment and health system functions that influence outcomes, such as service quality, continuity of care, and the ability of providers and systems to identify and address gaps along the HIV care cascade.
Another core theme is sustainability and transition. HS3 is not only meant to help the GoDR achieve epidemic control outcomes during the project period, but also to prepare government structures and "safety-net" private providers that serve key and priority populations to continue operating effectively as donor funding decreases. This includes strengthening coordination, service delivery capacity, and system-level practices that allow HIV programs to function reliably over time, particularly for communities that may depend on specialized or community-linked private providers for stigma-free access to care.
From an administrative standpoint, the opportunity is listed under Funding Opportunity Number 72051718RFA00003 and CFDA 98.001, with an unrestricted eligibility category (meaning any qualified entity may apply). It was released by USAID-Santo Domingo (Dominican Republic), with an original closing date of August 31, 2018. The stated award ceiling is USD 19,500,000. Overall, HS3 is framed as a catalytic investment intended to speed progress toward epidemic control by pairing direct clinical service improvements for key and priority populations with deliberate health system strengthening so that improvements last beyond the life of the award.Apply for 72051718RFA00003
- The Dominican Republic USAID-Santo Domingo in the health sector is offering a public funding opportunity titled "HIV Services and Systems Strengthening (HS3)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001.
- This funding opportunity was created on 2018-07-31.
- Applicants must submit their applications by 2018-08-31. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $19,500,000.00 in funding.
- Eligible applicants include: Unrestricted.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs): USAID/PEPFAR HIV Services and Systems Strengthening (HS3) - Dominican Republic
1) What is this funding opportunity?
This is a USAID continuation funding opportunity, issued through the USAID Mission in the Dominican Republic under the President's Emergency Plan for AIDS Relief (PEPFAR), to support the HIV Services and Systems Strengthening (HS3) program.
2) What type of award is being offered?
The award mechanism is a cooperative agreement. This means the implementer carries out the work with substantial involvement from USAID (as opposed to a more hands-off relationship).
3) What is the main purpose of the HS3 program?
The central purpose of HS3 is to accelerate progress toward HIV epidemic control in the Dominican Republic while strengthening the underlying health system so results can be sustained and eventually transitioned away from donor support.
4) What time period does HS3 cover?
HS3 is positioned as a multi-year effort spanning 2018 to 2023.
5) What major HIV targets is HS3 designed to support?
HS3 is designed to accelerate progress toward the global 90-90-90 targets:
- 90 percent of people living with HIV know their HIV status
- 90 percent of those diagnosed receive sustained antiretroviral therapy (ART)
- 90 percent of those on treatment achieve viral suppression
6) How does HS3 plan to advance the 90-90-90 targets?
HS3 emphasizes improving clinical care and service delivery using a health systems strengthening (HSS) approach. It is framed as more than expanding individual services; it focuses on building a responsive, scalable HIV service platform that can identify and address bottlenecks across the HIV care cascade.
7) What does "health systems strengthening" mean in this opportunity?
Based on the opportunity description, HSS refers to strengthening the service platform and system functions that affect HIV outcomes. This includes improving service quality, continuity of care, and the ability of providers and systems to identify and fix gaps that prevent people from testing, linking to care, staying on treatment, and reaching viral suppression.
8) Which parts of the HIV care cascade are specifically emphasized?
The opportunity highlights removing barriers and addressing bottlenecks related to:
- HIV testing (knowing HIV status)
- Linkage to care after diagnosis
- Retention on treatment
- Viral suppression among those on treatment
9) Who are the key populations prioritized by HS3?
The opportunity defines key populations as:
- Men who have sex with men (MSM)
- Transgender individuals (TG)
- Female sex workers (FSW)
10) Who are the priority populations identified in the opportunity?
The opportunity defines priority populations as migrants of Haitian descent.
11) Why does HS3 emphasize key and priority populations?
HS3 is designed to ensure HIV services effectively reach and serve groups that are disproportionately affected by HIV or face greater barriers to accessing services. The program aims to deliver targeted, high-impact service packages for these groups while reinforcing the broader service environment and system functions that influence outcomes.
12) What kind of service approach is HS3 trying to build?
HS3 emphasizes a more responsive and scalable HIV service platform that can adapt to changing needs, identify bottlenecks, and remove barriers along the care continuum. The activity is positioned as both a direct service improvement effort and a system-strengthening effort.
13) What is meant by "sustainability and transition" in HS3?
Sustainability and transition refers to preparing Government of the Dominican Republic (GoDR) structures and "safety-net" private providers that serve key and priority populations to continue operating effectively as donor funding decreases, so gains can last beyond the award period.
14) What role does the Government of the Dominican Republic (GoDR) play in HS3?
The program is intended to help the GoDR move closer to HIV epidemic control and strengthen government systems so improvements can be sustained and transitioned away from donor support over time.
15) How does HS3 relate to private providers?
The opportunity highlights strengthening "safety-net" private providers that serve key and priority populations, particularly where specialized or community-linked private providers may offer stigma-free access to care for communities that face barriers in other settings.
16) What is the funding opportunity number (FON) for this announcement?
The Funding Opportunity Number is 72051718RFA00003.
17) What CFDA number is associated with this opportunity?
The CFDA number listed is 98.001.
18) Who issued the opportunity?
The opportunity was released by USAID-Santo Domingo in the Dominican Republic, under PEPFAR.
19) Who is eligible to apply?
The eligibility category is described as unrestricted, meaning any qualified entity may apply.
20) What is the maximum funding amount (award ceiling)?
The stated award ceiling is USD 19,500,000.
21) What was the closing date for applications?
The original closing date stated for this opportunity was August 31, 2018.
22) Is this opportunity described as a one-time project or a long-term effort?
It is framed as a multi-year, catalytic investment (2018-2023) intended to speed progress toward epidemic control while building lasting system improvements beyond the life of the award.
23) What is the program's overall strategy in one sentence?
HS3 aims to speed progress toward HIV epidemic control by pairing direct clinical service improvements for key and priority populations with deliberate health system strengthening so improvements last beyond the award period.
Browse more opportunities from the same category: Health
Next opportunity: US Ambassadors Fund for Cultural Preservation (AFCP), Large Grants Competition, US Embassy San Salvador
Previous opportunity: 2019 YSEALI Regional Workshop: Entrepreneurship and the Environment
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for 72051718RFA00003
Applicants also applied for:
Applicants who have applied for this opportunity (72051718RFA00003) also looked into and applied for these:
| Funding Opportunity |
|---|
| Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional) Apply for RFA MD 18 010 Funding Number: RFA MD 18 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) Apply for RFA MD 18 009 Funding Number: RFA MD 18 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Management of Asthma in Primary Care - Clinical Center (UG3/UH3 - Clinical Trial Required) Apply for RFA HL 19 005 Funding Number: RFA HL 19 005 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Management of Asthma in Primary Care - Bioinformatics Center (U24 - Clinical Trial Required - Infrastructure) Apply for RFA HL 19 006 Funding Number: RFA HL 19 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alzheimer Centers for Discovery of New Medicines (U54 Clinical Trial Not Allowed) Apply for RFA AG 19 010 Funding Number: RFA AG 19 010 Agency: National Institutes of Health Category: Health Funding Amount: $5,250,000 |
| 2019 YSEALI Regional Workshop: Partnership in Health – Community-based Prevention for Non-communicable Diseases and Mental Health Apply for PAS ID 18 003 Funding Number: PAS ID 18 003 Agency: U.S. Mission to Indonesia Category: Health Funding Amount: $250,000 |
| Limited Competition: Renewal of, and Revisions to, the Alzheimer's Disease Genetics Consortium (U01 Clinical Trial Not Allowed) Apply for PAR 18 889 Funding Number: PAR 18 889 Agency: National Institutes of Health Category: Health Funding Amount: $2,500,000 |
| Limited Competition: Additional Sequencing for the Alzheimer's Disease Sequencing Project: Opportunity for Revision Requests for Active Cooperative Agreements (U01 Clinical Trial Not Allowed) Apply for PAR 18 890 Funding Number: PAR 18 890 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Neuroprotection (U01 Clinical Trial Not Allowed) Apply for RFA NS 18 033 Funding Number: RFA NS 18 033 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing Extracellular RNA (exRNA) Communication Research: Improved Isolation and Analysis of exRNA-Carrier Subclasses (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA RM 18 027 Funding Number: RFA RM 18 027 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited competition: Data Management and Resource Repository (DMRR) on Extracellular RNA (U54 Clinical Trial Not Allowed) Apply for RFA RM 18 026 Funding Number: RFA RM 18 026 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Neuroprotection - Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA NS 18 034 Funding Number: RFA NS 18 034 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Advancing Extracellular RNA (exRNA) Communication Research: Towards Single Extracellular Vesicle (EV) Sorting, Isolation, and Analysis of Cargo (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA RM 18 028 Funding Number: RFA RM 18 028 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIMHD Minority Health and Health Disparities Research Training (MHRT) Program (T37) Apply for RFA MD 18 007 Funding Number: RFA MD 18 007 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Mental Health Research Dissertation Grant to Enhance Workforce Diversity (R36 Independent Clinical Trial Not Allowed) Apply for PAR 18 894 Funding Number: PAR 18 894 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| CNS-Targeted Drug Delivery Strategies for HIV (R01 Clinical Trial Not Allowed) Apply for PAR 18 895 Funding Number: PAR 18 895 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Trial on Effects of Statins in Older Adults without Clinical Cardiovascular Disease (U19 Clinical Trial Required) Apply for RFA AG 19 020 Funding Number: RFA AG 19 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional) Apply for RFA MH 19 240 Funding Number: RFA MH 19 240 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (X02 Clinical Trial Not Allowed) Apply for PAR 18 899 Funding Number: PAR 18 899 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Innovative Adaptations to Simplify Existing Technologies for Manipulation and Analysis of Glycans (U01 Clinical Trial Not Allowed) Apply for RFA RM 18 037 Funding Number: RFA RM 18 037 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "72051718RFA00003", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.